Octagon Capital Advisors LP / CYTK
Octagon Capital Advisors LP’s Cytokinetics Inc Position
Does Octagon Capital Advisors LP own Cytokinetics Inc (CYTK)? Not currently — the last reported position was 194.0K shares worth $14M in Q1 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$14M
Q1 2024
Shares
194.0K
% of Portfolio
+1.63%
Quarters Held
2
position exited
Position History CYTK
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Octagon Capital Advisors LP’s full portfolio or all institutional holders of CYTK.